Recruiting
Phase 2

Acalabrutinib & Obinutuzumab

Sponsor:

Emory University

Code:

NCT04883437

Conditions

Grade 1 Follicular Lymphoma

Grade 2 Follicular Lymphoma

Grade 3a Follicular Lymphoma

Indolent Non-Hodgkin Lymphoma

Lymphoplasmacytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Acalabrutinib

Obinutuzumab

Quality-of-Life Assessment

Questionnaire Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Emory University on 2025-03-27.